Indrayani Biotech 관리

관리 기준 확인 3/4

Indrayani Biotech's CEO is Kasiraman Sundar, appointed in Feb 2018, has a tenure of 6.75 years. directly owns 5.78% of the company’s shares, worth ₹122.79M. The average tenure of the management team and the board of directors is 4 years and 5.3 years respectively.

주요 정보

Kasiraman Sundar

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	6.8yrs
CEO 소유권	5.8%
경영진 평균 재임 기간	4yrs
이사회 평균 재임 기간	5.3yrs

최근 관리 업데이트

Recent updates

CEO

Kasiraman Sundar (63 yo)

6.8yrs

테뉴어

Mr. Kasiraman Sayee Sundar has been Executive Director and Managing Director of Indrayani Biotech Ltd since February 17, 2018. He has experience in Real Time Embedded Systems & Firmware Development and was...

리더십 팀

이름	위치	테뉴어	보상	소유권
Kasiraman Sundar	MD & Executive Director	6.8yrs	데이터 없음	5.78% ₹ 122.8m
Singarababu Indirakumar	Whole Time Director	4.3yrs	₹1.83m	데이터 없음
G. Swaminathan	Whole-Time Director	4.3yrs	데이터 없음	9.09% ₹ 193.2m
Muthukrishnan Ramesh	Whole Time Director	3.6yrs	₹2.82m	2.31% ₹ 49.0m
Vinayaka Bodala	Chief Financial Officer	3.8yrs	데이터 없음	데이터 없음
V. Santhanakrishnan	Company Secretary & Compliance Officer	less than a year	데이터 없음	데이터 없음
Mary Sujatha	Head of Human Resource	no data	데이터 없음	데이터 없음
Dhinakaran Rajagopal	Chief Co-ordinating Officer	no data	데이터 없음	데이터 없음

4.0yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 관리: 526445's management team is considered experienced (4 years average tenure).

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kasiraman Sundar	MD & Executive Director	6.8yrs	데이터 없음	5.78% ₹ 122.8m
Singarababu Indirakumar	Whole Time Director	4.3yrs	₹1.83m	데이터 없음
G. Swaminathan	Whole-Time Director	4.3yrs	데이터 없음	9.09% ₹ 193.2m
Muthukrishnan Ramesh	Whole Time Director	3.8yrs	₹2.82m	2.31% ₹ 49.0m
Nangavaram Ranganathan	Independent Chairman of the Board	6.3yrs	데이터 없음	데이터 없음
Kannimangalam Vaidyanathan	Independent Director	6.3yrs	데이터 없음	0.022% ₹ 466.6k
Lakshmiprabha Kasiraman	Non Independent Non-Executive Women Director	6.3yrs	데이터 없음	0.0077% ₹ 163.4k
Bokara Nagarajan Priyadharshini	Independent Director	3.7yrs	데이터 없음	데이터 없음

5.3yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: 526445's board of directors are considered experienced (5.3 years average tenure).

Indrayani Biotech 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Indrayani Biotech Limited, Annual General Meeting, Aug 22, 2024

Insufficient new directors

Indrayani Biotech Limited Announces Company Secretary & Compliance Officer Changes

Indrayani Biotech Limited Announces Executive Changes

Indrayani Biotech Limited, Annual General Meeting, Sep 30, 2022

Indrayani Biotech Limited Approves Constitution the Allotment Committee

Recent updates

Investor sentiment improves as stock rises 21%

First quarter 2025 earnings released: EPS: ₹0.10 (vs ₹0.09 loss in 1Q 2024)

Indrayani Biotech Limited to Report Q1, 2025 Results on Aug 14, 2024

Indrayani Biotech Limited, Annual General Meeting, Aug 22, 2024

Investor sentiment improves as stock rises 15%

Full year 2024 earnings released: EPS: ₹1.40 (vs ₹2.55 in FY 2023)

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 21%

Now 21% undervalued after recent price drop

Insufficient new directors

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

Indrayani Biotech Limited Announces Company Secretary & Compliance Officer Changes

Second quarter 2024 earnings released: EPS: ₹0.89 (vs ₹1.54 in 2Q 2023)

New minor risk - Shareholder dilution

Indrayani Biotech Limited to Report Q3, 2024 Results on Feb 14, 2024

First quarter 2024 earnings released: ₹0.09 loss per share (vs ₹0.52 profit in 1Q 2023)

Indrayani Biotech Limited to Report Q1, 2024 Results on Aug 11, 2023

New major risk - Financial position

New major risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.95 (vs ₹1.30 in FY 2022)

Indrayani Biotech Limited to Report Q4, 2023 Results on May 30, 2023

Indrayani Biotech Limited Announces Executive Changes

Investor sentiment improves as stock rises 19%

Third quarter 2023 earnings released: EPS: ₹0.72 (vs ₹0.33 in 3Q 2022)

Indrayani Biotech Limited (BSE:526445) acquired 51% stake in Matrix Boilers Private Limited for INR2.8 million.

Investor sentiment improved over the past week

Indrayani Biotech Limited to Report Q2, 2023 Results on Nov 14, 2022

Investor sentiment deteriorated over the past week

Indrayani Biotech Limited, Annual General Meeting, Sep 30, 2022

Investor sentiment improved over the past week

Indrayani Biotech Limited to Report Q1, 2023 Results on Aug 13, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Indrayani Biotech Limited to Report Q4, 2022 Results on May 30, 2022

Indrayani Biotech Limited announced that it has received INR 235.16798 million in funding

Indrayani Biotech Limited Approves Constitution the Allotment Committee

Indrayani Biotech Limited Announces Management Changes

Indrayani Biotech Limited Appoints Krishnamurthi Ravichandran as the Secretarial Auditor of the Company for the Financial Year 2021-22

Indrayani Biotech Limited to Report Q3, 2022 Results on Feb 14, 2022

Indrayani Biotech Limited Appoints Muthu Krishnan Ramesh as Additional Director

Indrayani Biotech Limited to Report Fiscal Year 2020 Results on Nov 28, 2020

Indrayani Biotech Limited to Report Q1, 2021 Results on Aug 29, 2020

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령